Cannabis Retailers Shift From Risky Bet to Mainstay in Commercial Leasing
Landlords and brokers report surging demand for dispensary tenants as retail cannabis proves durable across market cycles.

Front view of a cannabis accessory store's illuminated facade at night, creating a moody urban scene.
Dispensary Tenants Outperform Traditional Retail on Lease Metrics
Cannabis retailers now post lower default rates and higher revenue-per-square-foot figures than apparel, electronics, and general merchandise tenants in comparable strip-center locations. Brokers in California, Illinois, and New Jersey report that dispensary operators routinely pay $60–$120 per square foot triple-net in high-traffic corridors, a premium justified by gross margins unavailable to conventional retail. Lease terms have stabilized at five-to-ten-year commitments with built-in renewals, a marked change from the two-to-three-year trial leases common before 2023.
Landlords initially viewed cannabis as a regulatory gamble. That changed. Three years of consistent rent payments and minimal tenant turnover have rewritten underwriting models. One Chicago-based REIT principal noted that dispensaries weathered the 2024–2025 consumer pullback better than adjacent QSR and fitness tenants, maintaining foot traffic even as discretionary spending declined.
Institutional Landlords Enter the Market After Years on Sidelines
Publicly traded REITs and pension-fund-backed landlords, once barred by internal policy from cannabis tenants, are now actively courting dispensary operators in adult-use states. Policy reversed after federal banking reforms enacted in late 2024 and updated guidance from the Office of the Comptroller of the Currency clarifying that lease income from state-licensed cannabis businesses doesn't constitute money laundering. Legal opinions obtained by institutional owners in 2025 further insulated landlords from asset-forfeiture risk under the Controlled Substances Act.
Two national retail REITs disclosed cannabis-tenant exposure in Q2 2026 earnings calls, with combined lease revenue exceeding $18 million annually. Private equity–backed retail portfolios have quietly added dispensary tenants since mid-2025, treating cannabis as a credit-tenant class equivalent to urgent care or specialty grocery.
Zoning and Proximity Rules Still Constrain Site Selection
Despite landlord appetite, dispensary expansion remains bottlenecked by municipal zoning ordinances that limit cannabis retail to industrial corridors or impose 1,000-foot buffers from schools, parks, and daycare facilities. In densely populated markets such as New York City and Boston, compliant sites command bidding wars. A South Boston retail bay zoned for cannabis drew 11 offers in July 2026. The winning tenant paid a $200,000 key-money premium on top of base rent.
Operators report that site-selection timelines stretch six to nine months longer than for conventional retail due to municipal hearings, community-board approvals, and state agency pre-qualification. That friction benefits landlords with pre-approved sites, who can extract above-market rents from tenants facing limited alternatives.
European and Canadian Precedents Inform U.S. Landlord Strategy
U.S. landlords are studying lease structures pioneered in Germany, the Netherlands, and Canada, where cannabis retail has operated under regulated frameworks for years. German pharmacies dispensing medical cannabis under BfArM licenses typically occupy ground-floor retail in mixed-use buildings—a model U.S. developers are replicating in states permitting co-location with medical offices. Health Canada's storefront-distance rules, which proved unenforceable in Toronto and Vancouver, have informed U.S. municipalities' decisions to relax similar buffers.
Canada's oversupply crisis and subsequent retailer bankruptcies in 2020–2022 remain a cautionary tale. Yet the durability of dispensaries in mature markets such as Ontario and British Columbia has reassured U.S. capital allocators. One Vancouver landlord's portfolio, 40% cannabis-tenanted since 2019, reported zero lease defaults through the pandemic and subsequent market correction.
Tenant Improvement Allowances and Build-Out Costs Create Friction
Dispensary build-outs cost $250–$400 per square foot, roughly double the outlay for conventional retail, driven by vault requirements, security infrastructure, and HVAC systems that meet state product-storage regulations. Landlords in competitive markets now offer tenant improvement allowances of $50–$100 per square foot to secure creditworthy operators, a concession rarely extended to other retail categories. These allowances reflect landlords' recognition that a fully built dispensary is a sunk cost with limited alternative-use value if the tenant vacates.
Operators push for longer amortization periods on TI allowances, arguing that state license uncertainty and federal rescheduling debates justify 10-year payback terms. Landlords counter that cannabis tenants' superior cash flow supports faster amortization. Negotiations typically land at seven years.
Secondary Markets See Dispensary-Led Retail Revitalization
Cannabis retailers are anchoring redevelopment projects in secondary markets where traditional retail has fled, particularly in Rust Belt cities and rural corridors with limited chain-store interest. A former Kmart in Youngstown, Ohio, subdivided into four dispensary storefronts in 2025, now generates $1.2 million in annual rent—triple the pre-cannabis vacancy rate. Similar conversions have occurred in upstate New York, Pennsylvania, and Michigan, where dispensaries occupy big-box shells too large for single tenants but viable when demised.
Economic-development officials question whether cannabis retail constitutes sustainable job creation or merely displaces consumer spending from other categories. Early data from Illinois suggests modest net employment gains, with dispensaries hiring 12–18 full-time-equivalent employees per location, comparable to mid-sized grocery or pharmacy tenants.
What Landlords Are Watching in the Next 12 Months
The key variable for landlords is federal rescheduling's impact on dispensary margins and, by extension, rent-paying capacity. If the DEA's proposed move of cannabis to Schedule III takes effect in 2027, operators will gain access to standard business deductions under Section 280E, potentially boosting net income by 20–40%. Landlords expect operators to reinvest those savings in expansion rather than rent increases, but lease renewals signed post-rescheduling will test that assumption.
For context on how federal policy shifts ripple through cannabis real estate, see the CannIntel topic hub on Cannabis Retail Real Estate. Another watch item: state-level market saturation. New York, New Jersey, and Ohio are issuing licenses faster than demand can absorb, raising the risk of a Canada-style shakeout. Landlords with multi-tenant exposure are stress-testing portfolios against 15–20% dispensary failure rates, a prudent hedge given the sector's youth.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

New York CBD Stores Face Dispensary Squeeze as Adult-Use Expands
Legacy hemp retailers pivot to wellness, education, and niche products as licensed cannabis shops multiply statewide.

Michigan Retailer Closes Five Dispensaries Citing New Tax Burden
A Michigan cannabis operator is shuttering five locations as the state's revised tax structure squeezes multi-location retailers.

Michigan Dispensary Chain Closes Five Stores, Blames 24% Tax Rate
An unnamed multi-location operator shuttered five Michigan cannabis retail locations this week, citing the state's combined 24% tax burden as the primary driver.
More from the newsroom

Maine Medical Cannabis Operator Sues Ellsworth Over License Denials
A multi-location operator filed suit challenging the city's refusal to approve additional dispensary licenses.

MMJ Challenges CMS Administrator Oz Over Hemp Cannabinoid Endorsement
Medical marijuana operator disputes federal 'no product' stance after CMS head endorses unvalidated hemp-derived cannabinoid line.

Federal Judge Denies Request to Block Texas Hemp Ban
A U.S. district court rejected industry arguments for a temporary restraining order, leaving the state's consumable hemp prohibition in effect.